ArticleBMC cardiovascular disorders2025
Right ventricular-pulmonary coupling and tissue hypoperfusion: a combined echocardiographic and metabolic approach to prognosticate cardiogenic shock.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Right ventricular-pulmonary arterial uncoupling: an underrecognized predictor of in-hospital outcomes in acute myocardial infarction.BMC cardiovascular disorders · 2026Article
- The relationship between lactate-to-albumin ratio and prognosis in patients with sepsis-induced cardiomyopathy: a retrospective cohort study.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiogenic shock (CS) remains a high-mortality condition. Effective risk stratification is crucial for guiding management. This study evaluated the combined prognostic utility of the tricuspid annular plane systolic excursion(TAPS) to pulmonary artery systolic pressure (PASP) ratio, a measure of right ventricular-pulmonary coupling, and lactate, a marker of tissue hypoperfusion, in intensive care unit (ICU) patients with CS.
methodsA retrospective cohort study was conducted on 221 ICU patients diagnosed with CS (SCAI shock stages B-E). Echocardiographic parameters (including TAPS/PASP) and arterial lactate levels were obtained within 24 h of diagnosis. The primary outcome was 28-day mortality. Univariate and multivariate Cox proportional hazards regression, Kaplan-Meier survival analysis, and receiver operating characteristic (ROC) curve analysis were performed.
resultsBoth TAPS/PASP ratio (HR = 0.689, p = 0.003) and lactate (HR = 1.498, p = 0.003) were independently associated with 28-day mortality. Patients with low TAPS/PASP and high lactate had significantly lower survival. A combined model incorporating both parameters demonstrated superior predictive performance for 28-day mortality (AUC = 0.703) compared to TAPS/PASP (AUC = 0.671) or lactate (AUC = 0.650) alone. A non-linear relationship was observed between TAPS/PASP and lactate.
conclusionThe combined assessment of TAPS/PASP ratio and lactate levels provides enhanced prognostic information in patients with cardiogenic shock. This integrated approach, incorporating both cardiac function and metabolic biomarkers, may improve risk stratification and facilitate more targeted therapeutic interventions in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.